Current Risk Scores Miss Nearly Half of First Heart Attacks Nearly half of adults with a first myocardial infarction show low or borderline risk on current risk estimators Most develop symptoms only within 48 hours and would not qualify for statins earlier
Does Depression Speed Up ASCVD Onset and Treatment? - Medscape Patients with depression may develop atherosclerotic cardiovascular disease earlier and start treatment more often than those without depression but achieve similar cholesterol control, a study finds
Low-Dose Colchicine Approved for CVD: Now What? - Medscape The recent US approval of a new low dose of colchicine 0 5 mg (Lodoco; Agepha Pharma) with a broad indication for use in atherosclerotic cardiovascular disease (ASCVD) represents a completely new
Lp (a): Aiming at a Moving Target, Waiting for Ammunition Patients in the study — which used > 70 mg dL (or 150 nmol L) as a threshold for predicting ASCVD complications — with peripheral artery disease and elevated Lp (a) were at 57% greater risk
Good Performance for Universal CVD Risk Prediction Model A universal cardiovascular disease (CVD) prediction tool performs well in patients with and without atherosclerotic CVD (ASCVD), a new study showed, suggesting this model could facilitate